MedTrace Logo

Performance Characteristics and Safety Assessment of a Non-invasive Glucose Monitoring Device

NCT03352518 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-10-15

No results posted yet for this study

Summary

This clinical study has been launched to collect spectral raman data paired with validated glucose reference values in private homes of subjects.

Conditions

Interventions

DEVICE

WM3.4NR

The investigational medical device will collect spectral raman data from tissue.

Sponsors & Collaborators

  • RSP Systems A/S

    lead INDUSTRY

Principal Investigators

  • Jan Erik Henriksen, MD · University Hospital Odense

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-28
Primary Completion
2018-04-13
Completion
2018-04-17

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03352518 on ClinicalTrials.gov